您是记者吗？

了解 ALK

如有任何疑问，请直接联系 ALK 总部或任何全球办事处的媒体关系部。

The press releases in this press room contains information that is of general news value for the press, and available for journalists or media with a view to journalistic assessment and preparation before publication.

News

See all
  • Post date
    04/15/2026
    neffy® approved as the first needle-free anaphylaxis treatment of adults and children in Canada
    Read more
  • Post date
    04/08/2026
    Report on transactions with ALK-Abelló A/S B shares and associated securities by managerial staff
    Read more
  • Post date
    04/01/2026
    Grant of share-based long-term incentive instruments to members of the Board of Management and key employees
    Read more
  • Post date
    03/31/2026
    EURneffy 1 mg approved across the EU as the first and only needle-free adrenaline treatment for young children (≥15 kg) at risk of anaphylaxis
    Read more
  • Post date
    03/16/2026
    Annual General Meeting in ALK-Abelló A/S held on 16 March 2026
    Read more
  • Post date
    03/04/2026
    New data reveals 9 in 10 people prefer EURneffy, a needle-free nasal adrenaline spray, over auto-injectors
    Read more
  • Post date
    02/20/2026
    Henriette Mersebach to step down as ALK’s head of R&D
    Read more
  • Post date
    02/20/2026
    Annual report 2025: ALK delivers 15% revenue growth and 26% EBIT margin
    Read more
  • Post date
    02/20/2026
    Annual General Meeting in ALK-Abelló A/S on 16 March 2026
    Read more

媒体关系

投资者关系

Per Plotnikof

企业传播、

投资者关系和战略规划

副总裁

电话：+45 2261 2525

电子邮件：PPIDK@alk.net

 

媒体关系

Jeppe Ilkjær

企业传播

媒体关系经理

电话：+45 3050 2014

电子邮件：Jeppe.Ilkjaer@alk.net

公司简介
快速了解过敏症免疫治疗市场中的领导者 ALK 的概况
关键财务数据
阅读 ALK 的最新财务业绩
欢迎记者朋友随时联系 ALK 的媒体关系团队。

图片

查找各种可供下载的图片。
Steen Riisgaard, CEO
下载图片
Production facilities, Hørsholm
下载图片
alk_produktion6_0
Production facilities, Hørsholm
下载图片
alk_produktion3_1
Production facilities, Hørsholm
下载图片
alk_produktion5
Production facilities, Hørsholm
下载图片
Family_website_0
ALK HQ, Hørsholm
下载图片
最近更新: 2016.11.14